Literature DB >> 17325149

Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD.

Yoko Ogawa1, Mohammed S Razzaque, Kaori Kameyama, Go Hasegawa, Shigeto Shimmura, Masataka Kawai, Shinichiro Okamoto, Yasuo Ikeda, Kazuo Tsubota, Yutaka Kawakami, Masataka Kuwana.   

Abstract

PURPOSE: Uncontrolled fibrosis due to excessive accumulation of extracellular matrix proteins in the lacrimal glands of patients with chronic graft-versus-host disease (cGVHD) is well documented. Heat-shock protein 47 (HSP47) is involved in the molecular maturation of collagen and has been shown to have a fibrogenic role in various fibrotic diseases. In this study, the role of HSP47 in the pathogenesis of lacrimal gland of patients with cGVHD was investigated.
METHODS: The expression of HSP47, Ki67 (a proliferation marker), types I and III collagen, and alpha-smooth muscle actin (alpha-SMA) was examined in tissue sections and in primary cultures of fibroblasts obtained from the lacrimal glands of patients with cGVHD (n = 8) and Sjögren's syndrome (SS; n = 7).
RESULTS: Tissue sections of the lacrimal glands of patients with cGVHD showed markedly increased expression of HSP47 in fibroblasts around the medium-sized ducts than did those from patients with SS. The elevated expression of HSP47 in patients with cGVHD was mostly detected in Ki67-positive fibroblasts and was associated with increased accumulation of types I and III collagen in and around the fibrotic areas. Primary fibroblast cultures generated from cGVHD lacrimal gland showed higher HSP47 mRNA expression than did fibroblasts isolated from SS biopsy tissue, as determined by RT-PCR (P < 0.05). In contrast, alpha-SMA was higher in the SS than cGVHD fibroblasts at both mRNA and protein levels, and more lacrimal gland fibroblasts in the SS were positive for alpha-SMA than cGVHD (P < 0.01).
CONCLUSIONS: In cGVHD, increased expression of HSP47 may promote excessive collagen assembly in and around the periductal areas where fibroblasts are mostly in an active state. The less alpha-SMA in the cGVHD lacrimal gland fibroblasts suggests a relative lack of myofibroblastic transformation. It is likely that fibroblasts incapable of myofibroblastic transformation are the main source of HSP47 and collagen production, and the resultant effect is the periductal fibrotic changes seen in lacrimal glands of patients with cGVHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325149     DOI: 10.1167/iovs.06-0601

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD.

Authors:  Hiroyuki Ohigashi; Daigo Hashimoto; Eiko Hayase; Shuichiro Takahashi; Takahide Ara; Tomohiro Yamakawa; Junichi Sugita; Masahiro Onozawa; Masao Nakagawa; Takanori Teshima
Journal:  Blood Adv       Date:  2019-04-09

2.  Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.

Authors:  Lauren M Curtis; Manuel B Datiles; Seth M Steinberg; Sandra A Mitchell; Rachel J Bishop; Edward W Cowen; Jacqueline Mays; John M McCarty; Zoya Kuzmina; Filip Pirsl; Daniel H Fowler; Ronald E Gress; Steven Z Pavletic
Journal:  Haematologica       Date:  2015-06-18       Impact factor: 9.941

3.  Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease.

Authors:  Yoko Ogawa; Shigeto Shimmura; Tetsuya Kawakita; Satoru Yoshida; Yutaka Kawakami; Kazuo Tsubota
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

4.  Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells.

Authors:  Takashi Taguchi; Arifa Nazneen; Abdulmonem A Al-Shihri; Khadijah A Turkistani; Mohammed S Razzaque
Journal:  Acta Histochem Cytochem       Date:  2011-04-21       Impact factor: 1.938

5.  Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.

Authors:  Mio Yamane; Yoko Ogawa; Masaki Fukui; Mizuka Kamoi; Yumiko Saijo-Ban; Saori Yaguchi; Shin Mukai; Tetsuya Kawakita; Shigeto Simmura; Kazuo Tsubota
Journal:  Optom Vis Sci       Date:  2015-04       Impact factor: 1.973

6.  Influence of hyperprolactinemia on collagen fibers in the lacrimal gland of female mice.

Authors:  Ariadne Stavare Leal Araujo; Manuel de Jesus Simões; Carina Verna; Ricardo Santos Simões; José Maria Soares Júnior; Edmund Chada Baracat; Regina Célia Teixeira Gomes
Journal:  Clinics (Sao Paulo)       Date:  2015-09       Impact factor: 2.365

Review 7.  Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Yutaka Kawakami; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

8.  Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.

Authors:  Saori Yaguchi; Yoko Ogawa; Shigeto Shimmura; Tetsuya Kawakita; Shin Hatou; Shingo Satofuka; Shigeru Nakamura; Toshihiro Imada; Hideyuki Miyashita; Satoru Yoshida; Tomonori Yaguchi; Yoko Ozawa; Takehiko Mori; Shinichiro Okamoto; Yutaka Kawakami; Susumu Ishida; Kazuo Tsubota
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Role of heat shock protein 47 in transdifferentiation of human tenon's fibroblasts to myofibroblasts.

Authors:  Samin Hong; Kyoungsoo Park; Jin Hyoung Kim; Sueng-Han Han; Jong Bok Lee; Gong Je Seong
Journal:  BMC Ophthalmol       Date:  2012-09-11       Impact factor: 2.209

10.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.